In this study the: authors addressed the hypothesis that estrogen (i.e., 17
beta-estradiol) acts to repress leukocyte adhesion. The experiments involv
ed comparing leukocyte adhesion in cerebral venules in vivo, in intact ovar
iectomized and 17 beta-estradiol-treated (100 mu g/kg/day for 1 week) ovari
ectomized female rats using topical applications of the adhesion-promoting
drug, phorbol 12-myristate 13-acetate (PMA). Adherent Rhodamine-6G-labeled
leukocytes were viewed through a closed cranial window using intravital mic
roscopy/videometry. Leukocyte dynamics were recorded at baseline and after
each dose of PMA. The PMA was suffused (1.0 mL/min) at increasing concentra
tions (0.01, 0.1, and 1.0 mu mol/L, 15 minutes at each level). A videotape
record of each experiment was made for subsequent analysis of leukocyte adh
esion. The data showed that the percentage venular area occupied by adheren
t leukocytes at baseline was significantly greater in the ovariectomized co
mpared to the intact and 17 beta-estradiol-treated groups (12.2%, 3.4%, and
4.2% respectively). That relationship was maintained during PMA treatments
to the extent that the percentage venular area occupied by adherent leukoc
ytes increased to 26.4% in the untreated ovariectomized group compared to 1
4.4% and 11.3% in the intact and 17 beta-estradiol-treated groups, respecti
vely. In conclusion, the authors found chronic estrogen depletion enhances
leukocyte adhesion in the rat cerebral circulation, Estrogen repletion in s
uch animals is accompanied by a significant reduction in leukocyte adhesion
. These findings could, at least in part, account for the ischemic brain da
mage seen in ovariectomized versus intact females, and the restored neuropr
otection observed upon 17 beta-estradiol treatment reported in earlier stud
ies.